These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 31992661)
81. The PhenX Toolkit: standard measurement resources for cancer outcomes and survivorship research. Nekhlyudov L; Bellizzi K; Galligan A; King-Kallimanis B; Mayer DK; Miaskowski C; Salz T; McCarty C; Cox L; Hill C; Hendershot TP; Maiese DR; Hamilton CM J Natl Cancer Inst; 2023 Apr; 115(4):473-476. PubMed ID: 36661316 [TBL] [Abstract][Full Text] [Related]
82. Tobacco industry pricing undermines tobacco tax policy: A tale from Bangladesh. Nargis N; Hussain AKMG; Goodchild M; Quah ACK; Fong GT Prev Med; 2020 Mar; 132():105991. PubMed ID: 31954145 [TBL] [Abstract][Full Text] [Related]
83. Brand placement on price boards after tobacco display bans: a point-of-sale audit in Melbourne, Australia. Wakefield M; Zacher M; Scollo M; Durkin S Tob Control; 2012 Nov; 21(6):589-92. PubMed ID: 23002179 [TBL] [Abstract][Full Text] [Related]
84. Cigarette advertising in the Republic of Korea: a case illustration of The One. Dewhirst T; Lee WB Tob Control; 2012 Nov; 21(6):584-8. PubMed ID: 22517803 [No Abstract] [Full Text] [Related]
85. Point-of-sale tobacco advertising in Beirut, Lebanon following a national advertising ban. Salloum RG; Nakkash RT; Myers AE; Wood KA; Ribisl KM BMC Public Health; 2013 Jun; 13():534. PubMed ID: 23731766 [TBL] [Abstract][Full Text] [Related]
86. Genomic medicine implementation protocols in the PhenX Toolkit: tools for standardized data collection. Chung WK; Brothers K; Bradbury A; Chanprasert S; Orlando L; Torkamani A; Zierhut H; Ritchie MD; Phillips M; Schoden J; Maiese D; Hendershot T; Hamilton CM; Ramos EM Genet Med; 2021 Sep; 23(9):1783-1788. PubMed ID: 33972721 [TBL] [Abstract][Full Text] [Related]
87. Increasing Price and Reducing Access to Tobacco in New York City. Schroth KRJ J Law Med Ethics; 2019 Jun; 47(2_suppl):87-90. PubMed ID: 31298140 [TBL] [Abstract][Full Text] [Related]
88. Tobacco retail outlet advertising practices and proximity to schools, parks and public housing affect Synar underage sales violations in Washington, DC. Kirchner TR; Villanti AC; Cantrell J; Anesetti-Rothermel A; Ganz O; Conway KP; Vallone DM; Abrams DB Tob Control; 2015 Mar; 24(e1):e52-8. PubMed ID: 24570101 [TBL] [Abstract][Full Text] [Related]
89. A qualitative analysis of New Zealand retailers' responses to standardised packaging legislation and tobacco industry opposition. Guthrie J; Hoek J; Darroch E; Wood Z BMJ Open; 2015 Nov; 5(11):e009521. PubMed ID: 26553840 [TBL] [Abstract][Full Text] [Related]
90. Advancing the retail endgame: public perceptions of retail policy interventions. Whyte G; Gendall P; Hoek J Tob Control; 2014 Mar; 23(2):160-6. PubMed ID: 23842946 [TBL] [Abstract][Full Text] [Related]
91. EQUIPTMOD as a basis for rational investment decisions in tobacco control. Pokhrel S; West R Addiction; 2018 Jun; 113 Suppl 1():3-6. PubMed ID: 29644749 [No Abstract] [Full Text] [Related]
92. Influence of tobacco industry advertisements and promotions on tobacco use in India: findings from the Global Adult Tobacco Survey 2009-2010. Sinha DN; Palipudi KM; Oswal K; Gupta PC; Andes LJ; Asma S Indian J Cancer; 2014 Dec; 51 Suppl 1():S13-8. PubMed ID: 25526242 [TBL] [Abstract][Full Text] [Related]
93. "People over profits": retailers who voluntarily ended tobacco sales. McDaniel PA; Malone RE PLoS One; 2014; 9(1):e85751. PubMed ID: 24465682 [TBL] [Abstract][Full Text] [Related]
94. Creating demand for foreign brands in a 'home run' market: tobacco company tactics in South Korea following market liberalisation. Lee S; Lee K; Holden C Tob Control; 2014 May; 23(3):e8. PubMed ID: 23152099 [TBL] [Abstract][Full Text] [Related]
95. Single Cigarette Sales: State Differences in FDA Advertising and Labeling Violations, 2014, United States. Baker HM; Lee JG; Ranney LM; Goldstein AO Nicotine Tob Res; 2016 Feb; 18(2):221-6. PubMed ID: 25744967 [TBL] [Abstract][Full Text] [Related]
96. UK tobacco price increases: driven by industry or public health? Hiscock R; Branston JR; Partos TR; McNeill A; Hitchman SC; Gilmore AB Tob Control; 2019 Dec; 28(e2):e148-e150. PubMed ID: 31346068 [TBL] [Abstract][Full Text] [Related]
97. Tapping Into Multiple Data "Springs" to Strengthen Policy Streams: A Guide to the Types of Data Needed to Formulate Local Retail Tobacco Control Policy. Myers AE; Knocke K; Leeman J Prev Chronic Dis; 2019 Apr; 16():E43. PubMed ID: 30950786 [TBL] [Abstract][Full Text] [Related]
98. Recommendations and Challenges of the Clinical Services Panel of the PhenX Early Psychosis Working Group. Dixon L; Jones N; Loewy R; Perkins D; Sale T; Huggins W; Hamilton C Psychiatr Serv; 2019 Jun; 70(6):514-517. PubMed ID: 30966946 [TBL] [Abstract][Full Text] [Related]
100. Association between Tobacco Industry Interference Index (TIII) and MPOWER measures and adult daily smoking prevalence rate in 30 countries. Lee Y; Kim S; Kim MK; Kawachi I; Oh J Global Health; 2024 Jan; 20(1):6. PubMed ID: 38172937 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]